Exozymes Inc. held its Annual Meeting of Stockholders on July 25, 2025. During the meeting, shareholders elected six nominees to serve as directors. The 2025 Performance Equity Plan was approved. The appointment of RBSM LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exozymes Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-021084), on July 28, 2025, and is solely responsible for the information contained therein.